Therapeutic Lifestyle Changes Improve HDL Function by Inhibiting Myeloperoxidase-Mediated Oxidation in Patients With Metabolic Syndrome

類似資料

• Myeloperoxidase mediated HDL oxidation and HDL proteome changes do not contribute to dysfunctional HDL in Chinese subjects with coronary artery disease
  著者:: Wang, Guisong, 等
  出版事項: (2018)
• Impaired Amino Acid and TCA Metabolism and Cardiovascular Autonomic Neuropathy Progression in Type 1 Diabetes
  著者:: Mathew, Anna V., 等
  出版事項: (2019)
• Response to Comment on Mathew et al. Therapeutic Lifestyle Changes Improve HDL Function by Inhibiting Myeloperoxidase-Mediated Oxidation in Patients With Metabolic Syndrome. Diabetes Care 2018;41:2431–2437
  著者:: Mathew, Anna V., 等
  出版事項: (2019)
• Structured Lifestyle Intervention in Patients with the Metabolic Syndrome Mitigates Oxidative Stress but Fails to Improve Measures of Cardiovascular Autonomic Neuropathy
  著者:: Pennathur, Subramaniam, 等
  出版事項: (2017)
• Myeloperoxidase-derived oxidants damage artery wall proteins in an animal model of chronic kidney disease–accelerated atherosclerosis
  著者:: Zeng, Lixia, 等
  出版事項: (2018)